Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | DBH | P09172 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29970906 | 1.00 | CYP3A4 (0.50) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL3469757 | 0.84 | CYP3A4 (0.48) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL5940300 | 0.84 | HSD17B10 (0.52) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL27129026 | 0.80 | RAPGEF4 (0.39) | CYP3A4CHRM1ALOX15TBXA2RADRA1A | |
| SCHEMBL20561941 | 0.77 | HTR1D (0.35) | SIRT1ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL30937162 | 0.77 | HTR1D (0.35) | SIRT1ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22106260 | 0.75 | CYP3A4 (0.39) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL12401840 | 0.75 | HTR1D (0.47) | CYP3A4CHRM1ADRA1AHTR2BALDH1A1 | |
| SCHEMBL4681948 | 0.74 | TAAR1 (0.48) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL16095665 | 0.74 | HSD17B10 (0.42) | CYP3A4CHRM1ALOX15MAOATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12466781-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| US-11827596-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827596-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827596-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230242471-A1 | THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230242471-A1 | THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2023-08-03 | — | — | US | disclosed |
| US-11667606-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-11667606-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-11667606-B2 | Thyromimetics | AUTOBAHN THERAPEUTICS, INC. (US) | 2023-06-06 | — | — | US | disclosed |
| US-20230048992-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2023-02-16 | — | — | US | disclosed |
| CN-113423684-A | Novel thyromimetic agents | 速通医疗公司 | 2021-09-21 | — | — | CN | disclosed |
| WO-2021108549-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. (US) | 2021-06-03 | — | — | WO | disclosed |
| WO-2021108549-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. (US) | 2021-06-03 | — | — | WO | disclosed |
| US-20210053917-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2021-02-25 | — | — | US | disclosed |
| US-20210053917-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2021-02-25 | — | — | US | disclosed |
| US-20200361849-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2020-11-19 | — | — | US | disclosed |
| US-20200361849-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. | 2020-11-19 | — | — | US | disclosed |
| WO-2020118564-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020118564-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020123861-A1 | NOVEL THYROMIMETICS | AUTOBAHN THERAPEUTICS, INC. (US) | 2020-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667606-B2 | Thyromimetics | TPO, TSHR, TTR | CYP3A4 918/4885CHRM1 5/4885ALOX15 1864/4885 |
| US-20230048992-A1 | NOVEL THYROMIMETICS | TSHR, TPO, CHRM1 | CYP3A4 1258/4885CHRM1 3/4885ALOX15 1758/4885 |
| US-12466781-B2 | Thyromimetics | TPO, TSHR, CHRM1 | CYP3A4 1047/4885CHRM1 3/4885ALOX15 1781/4885 |
| US-20200361849-A1 | NOVEL THYROMIMETICS | TPO, THOP1, TSHR | CYP3A4 965/4885CHRM1 4/4885ALOX15 1244/4885 |
| US-20210053917-A1 | NOVEL THYROMIMETICS | TPO, TSHR, CHRM1 | CYP3A4 1132/4885CHRM1 3/4885ALOX15 1913/4885 |
| US-11827596-B2 | Thyromimetics | TPO, TSHR, TTR | CYP3A4 918/4885CHRM1 8/4885ALOX15 1416/4885 |
| US-20230242471-A1 | THYROMIMETICS | TPO, THOP1, THRB | CYP3A4 2516/4885CHRM1 122/4885ALOX15 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.